Universal Health Services stock trims 2026 guidance

Published on 09/16/2026 at 10:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Universal Health Services stock cut its 2026 EBITDA midpoint by about 3% on September 15, 2026. Acute admissions rose 2.9% in Q2, while EPS still points to 6% growth.

Moderne Klinikfassade mit Rettungswagen, Symbolbild für Universal Health Aktie — Fotorealistische Klinikfassade mit Rettungswagen zeigt Universal Health, Aktie ISIN US9139031002, moderne Gesundheitsversorgung dargestellt, Illustration mit AI erstellt.

Universal Health Services stock (ISIN US9139031002) traded at USD 176.75 on September 16, 2026, after a Tuesday session that left the shares up 2.0% and within a 52-week range of USD 140.08 to USD 246.32. The market cap stood at USD 10.42 billion, and volume reached 340,642 shares.

Guidance moved lower

At the 2026 Global Healthcare Conference on September 15, 2026, Universal Health Services said it revised 2026 guidance after a softer first quarter and stronger second-quarter volumes, according to Investing.com. The company cut the midpoint of EBITDA guidance by about 3%, while still projecting 3% EBITDA growth and 6% EPS growth for 2026, the transcript says.

That mix matters for investors because the 2.9% rise in acute care adjusted admissions in the second quarter was strong enough to lift the full-year acute admissions outlook to 2.5%, after 1.4% growth in the first half of 2026, according to the same transcript.

Policy pressure remains

The same conference update said exchange coverage losses are now expected to cost USD 85 million in 2026, up from USD 75 million, and that about USD 35 million of that hit already landed in the first half of the year. UHS also said it added 177 acute beds in the second quarter and expects West Henderson in Las Vegas to have kept benefiting from a broader local economy.

Behavioral care is the longer-term swing factor. UHS said it closed the Talkspace acquisition after the second quarter, giving it access to 6,000 therapists, and said it still captures only 3% to 5% of step-down patients today, with room to move into the double digits, according to Investing.com. The company also said outpatient Medicare accounts for 5% to 6% of total revenue and could rise about 8% if a proposed 2027 reimbursement rule is finalized.

Stock stays below the high

MarketBeat said on September 15, 2026 that Universal Health Services had a consensus Hold rating, an average price target of USD 204.93 and a 12-month range of USD 140.08 to USD 246.32. Against that backdrop, the stock closed at USD 176.75 on September 16, 2026, leaving it well below the high but above the low.